信函：益生菌在新冠疫情中的作用——作者回复
Letter: role of probiotics in the COVID-19 pandemic-authors' reply.
作者信息
Tian Yuan, Rong Long
机构信息
Department of Endoscopy Center, Peking University First Hospital, Beijing, China.
出版信息
Aliment Pharmacol Ther. 2020 Sep;52(5):933-934. doi: 10.1111/apt.15931.
Abstract
This article is linked to Tian et al and Aguila et al papers. To view these articles, visit https://doi.org/10.1111/apt.15731 and https://doi.org/10.1111/apt.15898
摘要
本文与田等人和阿吉拉等人的论文相关联。要查看这些文章，请访问https://doi.org/10.1111/apt.15731和https://doi.org/10.1111/apt.15898
相似文献
1
Letter: role of probiotics in the COVID-19 pandemic-authors' reply.信函：益生菌在新冠疫情中的作用——作者回复
Aliment Pharmacol Ther. 2020 Sep;52(5):933-934. doi: 10.1111/apt.15931.
2
Letter: probiotics? Yes, but which ones? Authors' reply.
Aliment Pharmacol Ther. 2019 Oct;50(8):968. doi: 10.1111/apt.15469.
3
Letter: meta-analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors' reply.信件：肠易激综合征中益生元、益生菌、合生元及抗生素的荟萃分析。作者回复。
Aliment Pharmacol Ther. 2019 May;49(9):1254-1255. doi: 10.1111/apt.15234.
4
Probiotics and COVID-19 - Authors' reply.益生菌与2019冠状病毒病——作者回复
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):722-723. doi: 10.1016/S2468-1253(20)30197-7.
5
Letter: probiotics vs. lactulose for minimal hepatic encephalopathy therapy--authors' reply.信件：益生菌与乳果糖用于轻微肝性脑病治疗——作者回复
Aliment Pharmacol Ther. 2014 May;39(9):1001. doi: 10.1111/apt.12700.
6
Letter: inflammatory bowel disease services during the Covid-19 pandemic - authors' reply.信件：Covid-19 大流行期间的炎症性肠病服务-作者回复。
Aliment Pharmacol Ther. 2022 Apr;55(8):1064. doi: 10.1111/apt.16884.
7
Letter: Lactobacillus rhamnosus GG offers no benefit over placebo in children with acute gastroenteritis. Authors' reply.信函：鼠李糖乳杆菌GG对急性肠胃炎儿童并无优于安慰剂的效果。作者回复。
Aliment Pharmacol Ther. 2019 Sep;50(5):622-623. doi: 10.1111/apt.15431.
8
Letter: is pneumococcal vaccination safe during the COVID-19 pandemic? Authors' reply.信件：在新冠疫情期间肺炎球菌疫苗接种是否安全？作者回复。
Aliment Pharmacol Ther. 2020 Sep;52(5):921-922. doi: 10.1111/apt.15940.
9
Letter: paying attention to the comorbidities or extraintestinal complications in patients with inflammatory bowel disease during the COVID-19 pandemic-authors' reply.信：在 COVID-19 大流行期间关注炎症性肠病患者的合并症或肠外并发症——作者的回复。
Aliment Pharmacol Ther. 2022 Jul;56(1):178. doi: 10.1111/apt.16977.
10
Letter: IBD nurse-pivotal role in the time of the pandemic. Authors' reply.信件：炎症性肠病护士在疫情期间的关键作用。作者回复。
Aliment Pharmacol Ther. 2020 Aug;52(4):746-747. doi: 10.1111/apt.15954.
引用本文的文献
1
Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review.益生菌、益生元、合生元和后生元作为COVID-19预防和治疗佐剂应用的证据与展望：文献计量分析与系统评价
Trends Food Sci Technol. 2022 Feb;120:174-192. doi: 10.1016/j.tifs.2021.12.033. Epub 2022 Jan 2.
本文引用的文献
1
Letter: role of probiotics in the COVID-19 pandemic.信函：益生菌在新冠疫情中的作用
Aliment Pharmacol Ther. 2020 Sep;52(5):931-932. doi: 10.1111/apt.15898.
2
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
3
[Management of COVID-19: the Zhejiang experience].[新型冠状病毒肺炎的管理：浙江经验]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(2):147-157. doi: 10.3785/j.issn.1008-9292.2020.02.02.
4
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.细菌和真菌合并感染冠状病毒的个体：一项支持 COVID-19 抗菌药物处方的快速综述。
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.
5
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.综述文章：COVID-19 的胃肠道特征和粪便传播的可能性。
Aliment Pharmacol Ther. 2020 May;51(9):843-851. doi: 10.1111/apt.15731. Epub 2020 Mar 31.
6
Emerging pathogenic links between microbiota and the gut-lung axis.肠道菌群与肺肠轴之间新出现的致病联系。
Nat Rev Microbiol. 2017 Jan;15(1):55-63. doi: 10.1038/nrmicro.2016.142. Epub 2016 Oct 3.
7
Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis.危重症中的益生菌和合生制剂疗法：一项系统评价与荟萃分析。
Crit Care. 2016 Aug 19;19:262. doi: 10.1186/s13054-016-1434-y.
8
The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia.肠道微生物群在宿主抵御肺炎球菌肺炎的防御中发挥保护作用。
Gut. 2016 Apr;65(4):575-83. doi: 10.1136/gutjnl-2015-309728. Epub 2015 Oct 28.
9
Regulation of lung immunity and host defense by the intestinal microbiota.肠道微生物群对肺部免疫和宿主防御的调节。
Front Microbiol. 2015 Oct 7;6:1085. doi: 10.3389/fmicb.2015.01085. eCollection 2015.
Zotero 插件